Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antibodies neutralizing GM-CSF for use in the treatment of rheumatoid arthritis or as analgesics

Antibodies neutralizing GM-CSF for use in the treatment of rheumatoid arthritis or as analgesics

US Patent 11795216 · Granted Oct 24, 2023

Estimated economic value: $27,359,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Vaccines for in vivo expression of nucleic acids and methods of using the same2025
Projectile, ammunition and method of manufacturing a projectile2025
Baler2025
Cutting knife for agricultural machine2025
Vaccine delivery systems using yeast cell wall particles2023
Vaccine delivery systems using yeast cell wall particles2023
Viral vaccines for in vivo expression of a nucleic acid encoding an immunogenic 2022
Combine harvester2022
Combine harvester2022
Vaccine delivery systems using yeast cell wall particles2021
Projectile, method of manufacturing a projectile and ammunition2021
Trailer hitch mounted recycling and waste container transporting apparatus2021